Table 1.

Literature findings concerning studies of electrochemotherapy (ECT) + immunotherapy.

Published Paper	Target	Treatment	Type of Study	Number of Patients	Responses (ORR)
Oncoimmunology 2015; 4: e1008842. Mozzillo et al. [36]	Advanced Melanoma	ECT + ipilimumab	Retrospective trial	15	67%
Anticancer Drugs 2017; 29: 190–196. Karaca et al. [20]	Advanced Melanoma	ECT + nivolumab	Case report	1	Not Applicable
Eur J Dermatol 2015; 25: 271–272. Brizio et al. [35]	Advanced Melanoma	ECT + ipilimumab	Case report	1	Not Applicable
Cancer Immunol Immunother 2016; 65: 951–959. Heppt et al. [38]	Advanced Melanoma	ECT + ipilimumab vs. ECT + anti-PD-1	Retrospective trial	33	59.2% adding the values obtained in the two arms